ACB
Price
$4.21
Change
-$0.03 (-0.71%)
Updated
Aug 7 closing price
Capitalization
238.86M
90 days until earnings call
SHIEF
Price
$0.04
Change
+$0.01 (+33.33%)
Updated
Jun 27 closing price
Capitalization
98.52M
Interact to see
Advertisement

ACB vs SHIEF

Header iconACB vs SHIEF Comparison
Open Charts ACB vs SHIEFBanner chart's image
Aurora Cannabis
Price$4.21
Change-$0.03 (-0.71%)
Volume$864.6K
Capitalization238.86M
Shield Therapeutics
Price$0.04
Change+$0.01 (+33.33%)
Volume$10K
Capitalization98.52M
ACB vs SHIEF Comparison Chart in %
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHIEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. SHIEF commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Buy and SHIEF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (ACB: $4.21 vs. SHIEF: $0.04)
Brand notoriety: ACB: Notable vs. SHIEF: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACB: 68% vs. SHIEF: 112%
Market capitalization -- ACB: $238.86M vs. SHIEF: $98.52M
ACB [@Pharmaceuticals: Other] is valued at $238.86M. SHIEF’s [@Pharmaceuticals: Other] market capitalization is $98.52M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileSHIEF’s FA Score has 0 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • SHIEF’s FA Score: 0 green, 5 red.
According to our system of comparison, SHIEF is a better buy in the long-term than ACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 3 TA indicator(s) are bullish while SHIEF’s TA Score has 2 bullish TA indicator(s).

  • ACB’s TA Score: 3 bullish, 5 bearish.
  • SHIEF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, SHIEF is a better buy in the short-term than ACB.

Price Growth

ACB (@Pharmaceuticals: Other) experienced а -4.97% price change this week, while SHIEF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.12%. For the same industry, the average monthly price growth was +73.14%, and the average quarterly price growth was +82.67%.

Reported Earning Dates

ACB is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.12% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACB($239M) has a higher market cap than SHIEF($98.5M). SHIEF YTD gains are higher at: 11.594 vs. ACB (-0.941). SHIEF has higher annual earnings (EBITDA): -21.41M vs. ACB (-1.64B). ACB has more cash in the bank: 149M vs. SHIEF (2.4M). SHIEF has less debt than ACB: SHIEF (0) vs ACB (103M). ACB has higher revenues than SHIEF: ACB (212M) vs SHIEF (3.07M).
ACBSHIEFACB / SHIEF
Capitalization239M98.5M243%
EBITDA-1.64B-21.41M7,645%
Gain YTD-0.94111.594-8%
P/E RatioN/AN/A-
Revenue212M3.07M6,908%
Total Cash149M2.4M6,198%
Total Debt103M0-
FUNDAMENTALS RATINGS
ACB vs SHIEF: Fundamental Ratings
ACB
SHIEF
OUTLOOK RATING
1..100
6937
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9097
PRICE GROWTH RATING
1..100
8344
P/E GROWTH RATING
1..100
9293
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACB's Valuation (57) in the Pharmaceuticals Other industry is in the same range as SHIEF (86) in the null industry. This means that ACB’s stock grew similarly to SHIEF’s over the last 12 months.

ACB's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as SHIEF (100) in the null industry. This means that ACB’s stock grew similarly to SHIEF’s over the last 12 months.

ACB's SMR Rating (90) in the Pharmaceuticals Other industry is in the same range as SHIEF (97) in the null industry. This means that ACB’s stock grew similarly to SHIEF’s over the last 12 months.

SHIEF's Price Growth Rating (44) in the null industry is somewhat better than the same rating for ACB (83) in the Pharmaceuticals Other industry. This means that SHIEF’s stock grew somewhat faster than ACB’s over the last 12 months.

ACB's P/E Growth Rating (92) in the Pharmaceuticals Other industry is in the same range as SHIEF (93) in the null industry. This means that ACB’s stock grew similarly to SHIEF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBSHIEF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
36%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
54%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
32%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
31%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
18%
View a ticker or compare two or three
Interact to see
Advertisement
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHIEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NODB57.25N/A
N/A
North Dallas Bank & Trust Co. (TX)
OLCLF21.74N/A
N/A
Oriental Land Co., Ltd.
PBMLF0.80N/A
N/A
Pacific Booker Minerals Inc.
TOKUY9.45N/A
N/A
Tokyu Corp.
JTCPF12.07-0.06
-0.54%
JTC PLC

SHIEF and

Correlation & Price change

A.I.dvisor tells us that SHIEF and TLRY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHIEF and TLRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHIEF
1D Price
Change %
SHIEF100%
N/A
TLRY - SHIEF
28%
Poorly correlated
+5.40%
CGC - SHIEF
26%
Poorly correlated
N/A
ACB - SHIEF
25%
Poorly correlated
-0.59%
IMCC - SHIEF
25%
Poorly correlated
+1.99%
CVSI - SHIEF
20%
Poorly correlated
+3.75%
More